InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Perl Jessica. Director active across 1 company, notably Emergent BioSolutions Inc.. Cumulatively, 5 reports have been published. History available since 9 February 2025. The latest transaction was disclosed on 29 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Jessica Perl is a declarant linked to Emergent BioSolutions Inc. on XNAS, where she is SVP, General Counsel, Corp Sec. She has 5 filings in total, and across the 5 recent filings observed between 2025-02-11 and 2026-05-01, both buy and sell amounts are 0 EUR, with tax withholding as the modal transaction nature.